Physiologic limitations during daily life activities in COPD patients

Respiratory Medicine

Volumn 104, Issue 8, 2010, Pages 1152-1159

  Lahaije, AJMC ^a   van Helvoort, HAC ^a   Dekhuijzen, PNR ^a   Heijdra, YF ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Activities of daily life; Chronic obstructive pulmonary disease; Dynamic hyperinflation; Dyspnea

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; LUNG FUNCTION; LUNG VENTILATION; MALE; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SPIROMETRY; SYMPTOM;

ACTIVITIES OF DAILY LIVING; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 77953911346     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.02.011     Document Type: Article

References (35)

1. Kinsman R.A., Yaroush R.A., Fernandez E., Dirks J.F., Schocket M., and Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest 83 5 (1983) 755-761
2. Hajiro T., Nishimura K., Tsukino M., Ikeda A., Oga T., and Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 116 6 (1999) 1632-1637
3. Reardon J.Z., Lareau S.C., and ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med 119 Suppl. 1 (2006) 32-37 10
4. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 9 (2005) 972-977
5. Watz H., Waschki B., Meyer T., and Magnussen H. Physical activity in patients with COPD. Eur Respir J 33 2 (2009) 262-272
6. Cooper C.B. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 119 Suppl. 1 (2006) 21-31 10
7. Oga T., Nishimura K., Tsukino M., Sato S., Hajiro T., and Mishima M. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 128 1 (2005) 62-69
8. Aliverti A., Macklem P.T., Debigare R., Maltais F., O'Donnell D.E., and Webb K.A. Point: counterpoint - the major limitations to exercise performance in COPD. J Appl Physiol 105 2 (2008) 749-755
9. Marin J.M., Carrizo S.J., Gascon M., Sanchez A., Gallego B., and Celli B.R. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 6 (2001) 1395-1399
10. O'Donnell D.E., Hamilton A.L., and Webb K.A. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 101 4 (2006) 1025-1035
11. Puente-Maestu L., Garcia de Pedro J., Martinez-Abad Y., Ruiz de Ona J.M., Llorente D., and Cubillo J.M. Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 128 2 (2005) 651-656
12. Ofir D., Laveneziana P., Webb K.A., Lam Y.M., and O'Donnell D.E. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177 6 (2008) 622-629
13. Aliverti A., and Macklem P.T. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles. J Appl Physiol 105 2 (2008) 749-751
14. Debigare R., and Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol 105 2 (2008) 751-753
15. Couser Jr. J.I., Martinez F.J., and Celli B.R. Respiratory response and ventilatory muscle recruitment during arm elevation in normal subjects. Chest 101 2 (1992) 336-340
16. Porto E.F., Castro A.A.M., Nascimento O., Oliveira R.C., Cardoso F., and Jardim J.R. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. Respir Med 103 2 (2009) 251-257
17. Palange P., Forte S., Onorati P., Manfredi F., Serra P., and Carlone S. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 88 5 (2000) 1715-1720
18. Troosters T., Vilaro J., Rabinovich R., Casas A., Barbera J.A., Rodriguez-Roisin R., et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 20 3 (2002) 564-569
19. van Helvoort H.A., Heijdra Y.F., de Boer R.C., Swinkels A., Thijs H.M., and Dekhuijzen P.N. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 131 2 (2007) 439-445
20. Casanova C., Cote C., de Torres J.P., Aguirre-Jaime A., Marin J.M., Pinto-Plata V., et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 6 (2005) 591-597
21. Dykstra B.J., Scanlon P.D., Kester M.M., Beck K.C., and Enright P.L. Lung volumes in 4,774 patients with obstructive lung disease. Chest 115 1 (1999) 68-74
22. MacIntyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26 4 (2005 Oct) 720-735
23. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 2 (2005) 319-338
24. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26 3 (2005) 511-522
25. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
26. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167 2 (2003) 211-277
27. O'Donnell D.E., and Webb K.A. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 148 5 (1993) 1351-1357
28. Stubbing D.G., Pengelly L.D., Morse J.L., and Jones N.L. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 49 3 (1980) 511-515
29. Yan S., Kaminski D., and Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156 1 (1997) 55-59
30. O'Donnell D.E., Voduc N., Fitzpatrick M., and Webb K.A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 1 (2004) 86-94
31. Jeng C., Chang W., Wai P.M., and Chou C.L. Comparison of oxygen consumption in performing daily activities between patients with chronic obstructive pulmonary disease and a healthy population. Heart Lung 32 2 (2003) 121-130
32. Velloso M., Stella S.G., Cendon S., Silva A.C., and Jardim J.R. Metabolic and ventilatory parameters of four activities of daily living accomplished with arms in COPD patients. Chest 123 4 (2003) 1047-1053
33. O'Donnell D.E., Fluge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 6 (2004) 832-840
34. Maltais F., Hamilton A., and Marciniuk D. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128 (2005) 1168-1178
35. Polkey M.I., and Rabe K.F. Chicken or egg: physical activity in COPD revisited. Eur Respir J 33 2 (2009) 227-229